Intellectual Property

The Human BioMolecular Research Institute (HBRI) has filed patent applications with the United States and other International Patent and Trademark Offices. For further information or for inquiries regarding licensing intellectual property at HBRI please contact Rebekah Handley, COO, 5310 Eastgate Mall, San Diego, CA 92121; Telephone (858) 458-9305; Fax: (858) 458-9311 or email: ip@hbri.org.


Technology and Agreements developed at HBRI falls into these broad categories:

Medications and Diagnostics
Medications and diagnostic technologies that are primarily useful in the development of drugs and diagnostics are often licensed exclusively.

Industry-Sponsored Research Agreements
Industry-Sponsored Research Agreements that support a specific research project in the lab generally include an option to license any jointly developed technology that may be generated as a result of the collaboration along with underlying HBRI technology.

Research Tools
Research tools are licensed non-exclusively for research purposes only. These include small molecules, proteins, antibodies, plasmids, genes and biomarkers.

Patents
The Human BioMolecular Research Institute (HBRI) has filed patents with the United States Patent and Trademark Office. For further information or for inquiries into licensing intellectual property at HBRI please contact Rebekah Handley, COO, 5310 Eastgate Mall, San Diego, CA 92121; Telephone (858) 458-9305; Fax: (858) 458-9311 or email: ip@hbri.org.

Technologies Available for Licensing
Looking for inventions or technology to commercialize? This site has an array of technologies listed across multiple categories that can be searched and licensed. With a direct link to HBRI technology, this is the best place to find new technologies online.

Current Technologies Available:

Metabolically Stable Agents for Alcohol and Drug Abuse

Compounds as Modulators of Smoking and Lung Cancer

Metabolically Stable Analgesics and Pain Medications

Modulators of CNS Neurotransmitters

Diagnostic Methods and Genetic Markers for Alzheimer’s Disease

Biomarkers for Organophosphate Exposure

Small Molecule Immunostimulants for Alzheimer’s Disease

Compounds to Decrease Nicotine Self-Administration

Oximes for Cholinesterase Reactivation

Compounds and Matrices for Use in Bone Growth and Repair

Compounds for Stem Cell Differentiation

Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells